Yale Catriona 4
4 · Akero Therapeutics, Inc. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Yale Catriona
Chief Development Officer
Transactions
- Sale
Common Stock
2025-09-11$43.02/sh−659$28,350→ 90,829 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person.